Sacituzumab govitecan is under clinical development by Gilead Sciences and currently in Phase II for Ovarian Cancer.

Gilead Sciences GILD announced that its first-in-class Trop-2-directed antibody-drug conjugate, Trodelvy (sacituzumab ...

The FDA granted breakthrough therapy designation to sacituzumab govitecan for patients with ES-SCLC progressing on platinum ...

In the study, Trodelvy (sacituzumab govitecan) met its objective of reducing progression-free survival in patients with HR-positive, HER2-negative metastatic breast cancer who received multiple ...

Our top content for the year highlight many challenges the field of non–small cell lung cancer (NSCLC) encountered, with data ...

Trodelvy (sacituzumab govitecan-hziy) is a brand-name IV infusion prescribed for certain types of breast cancer in adults. As with other drugs, Trodelvy can cause side effects, such as diarrhea ...

Trodelvy (sacituzumab govitecan-hziy) is a prescription drug that’s used to treat certain breast cancers. The drug comes as a powder that’s mixed with liquid to make a solution for intravenous ...

It was a busy week in the biotech sector with lots of regulatory and pipeline updates. Among bigwigs, Gilead Sciences, Inc.

Trodelvy (sacituzumab govitecan-hziy) is a brand-name injection for IV infusion that’s prescribed for certain breast cancers. Trodelvy has interactions with some other drugs. Examples include ...

Trodelvy (sacituzumab govitecan-hziy) is a prescription drug used to treat certain kinds of breast cancer. This drug can interact with some other medications. For example, Trodelvy can interact ...

INR:5297. bet365 founded The latest clinical progress of CRISPR/Cas9 gene editing therapy Everest Medicines' Phase 3 Clinical Trial Application for Sacituzumab Gov ...

rohit sharma ki wife Everest Medicines' Phase 3 Clinical Trial Application for Sacituzumab Govitecan Approved Pharmaceutical and Health Industry Weekly Report (September 23-September 27) [Two Sessions ...